UNP
48
6
PGR
58
6
EXPE
77
5
USB
46
3
XOM
42
2
ADI
45
-2
RL
72
3
VRTX
62
10
KSS
42
4
VZ
37
3
MDLZ
38
2
IPG
50
2
PH
71
4
AN
47
3
AVGO
32
7
MLM
58
-2
M
30
2
NUE
51
3
WY
53
2
AON
49
2
UNP
48
6
PGR
58
6
EXPE
77
5
USB
46
3
XOM
42
2
ADI
45
-2
RL
72
3
VRTX
62
10
KSS
42
4
VZ
37
3
MDLZ
38
2
IPG
50
2
PH
71
4
AN
47
3
AVGO
32
7
MLM
58
-2
M
30
2
NUE
51
3
WY
53
2
AON
49
2
Financhill
Back

TG Therapeutics Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Buy
60

TGTX
TG Therapeutics

Last Price:
25.85
Seasonality Move:
21.95%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

TG Therapeutics Price Quote

$25.85
-0.01 (5.73%)
(Updated: November 6, 2024 at 5:28 AM ET)

TG Therapeutics Key Stats

Buy
60
TG Therapeutics (TGTX) is a Buy
Day range:
$23.60 - $26.02
52-week range:
$9.81 - $26.99
Dividend yield:
0%
P/E ratio:
287.33
P/S ratio:
15.20
P/B ratio:
20.84%
Volume:
3.9M
Avg. volume:
2.7M
1-year change:
133.82%
Market cap:
$4B
Revenue:
$233.7M
EPS:
$-0.11

How Much Does TG Therapeutics Make?

Is TG Therapeutics Growing As A Company?

  • What Is TG Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.49%
  • What Is TG Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.97%

TG Therapeutics Stock Price Performance

  • Did TG Therapeutics Stock Go Up Last Month?
    TG Therapeutics share price went up by 16.33% last month
  • Did TGTX's Share Price Rise Over The Last Year?
    TGTX share price rose by 133.82% over the past 1 year

What Is TG Therapeutics 52-Week High & Low?

TG Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy TG Therapeutics?

  • How Much Debt Does TG Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does TG Therapeutics Have?
    Cash and short term investments quarterly total is $341M
  • What Is TG Therapeutics’s Book Value Per Share?
    Book value per share is 1.24

Is TG Therapeutics Cash Flow Positive?

  • What Is TGTX Cash Flow From Operations?
    Cash flow from operations (TTM) is $67.8M
  • What Is TG Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $565K
  • What Is TG Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$82.5M

TG Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TGTX return on invested capital is -5.71%
  • What Is TG Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -3.55%
  • What Is TGTX Return On Equity?
    ROE is a measure of profitability and is -8.4%

TG Therapeutics Earnings Date & Stock Price

TG Therapeutics Competitors

  • Who Are TG Therapeutics's Competitors?
    Below is a list of companies who compete with TG Therapeutics or are related in some way:
    • ADMA Biologics Inc (ADMA)
    • AdaptHealth Corp (AHCO)
    • Inspire Medical Systems Inc (INSP)
    • Rhythm Pharmaceuticals Inc (RYTM)
    • Varex Imaging Corp (VREX)

TG Therapeutics Dividend Yield

TG Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: -97.26% -40.92%
Revenue: -49.41% 2.66%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 37.00
Upside from Last Price: 43.08%

Major Shareholders

  • How many TGTX shares are owned by institutional investors?
    169.3M TGTX shares are owned by institutional investors
  • How many TGTX shares are owned by insiders?
    22.1M TGTX shares are owned by insiders